Acumen Pharmaceuticals to present Phase 2 trial data at CTAD

October 22, 2026 7:30 AM

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) will present three poster presentations at the 19th Annual Clinical Trials on Alzheimer's Disease (CTAD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found